Cargando…

Rehabilitation treatment of multiple sclerosis

Multiple sclerosis is a slowly progressive disease, immunosuppressants and other drugs can delay the progression and progression of the disease, but the most patients will be left with varying degrees of neurological deficit symptoms, such as muscle weakness, muscle spasm, ataxia, sensory impairment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Haoyang, Jing, Yuling, Li, Yinghua, Lian, Yawen, Li, Jianfang, Li, Zhenlan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117641/ https://www.ncbi.nlm.nih.gov/pubmed/37090712 http://dx.doi.org/10.3389/fimmu.2023.1168821

Ejemplares similares

Research progress in extracorporeal shock wave therapy for upper limb spasticity after stroke
por: Duan, Haoyang, et al.
Publicado: (2023)

The effects and underlying mechanism of extracorporeal shockwave therapy on fracture healing
por: Lv, Fuxian, et al.
Publicado: (2023)

Male and female are not the same: a multicenter study of static and dynamic functional connectivity in relapse-remitting multiple sclerosis in China
por: Wang, Yao, et al.
Publicado: (2023)

Clinical application of transcranial magnetic stimulation in multiple sclerosis
por: Zhou, Xiaoliang, et al.
Publicado: (2022)

The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022)

Progress in the clinical application of constraint-induced therapy following stroke since 2014
por: Cui, Yinxing, et al.
Publicado: (2023)

The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2023)

Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target
por: Liu, Rongzeng, et al.
Publicado: (2022)

The different damage patterns of short-, middle- and long-range connections between patients with relapse-remitting multiple sclerosis and neuromyelitis optica spectrum disorder
por: Chen, Xiaoya, et al.
Publicado: (2022)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS
por: Dou, Mengmeng, et al.
Publicado: (2021)

The Role of Astrocytes in Multiple Sclerosis
por: Ponath, Gerald, et al.
Publicado: (2018)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Digital Twins for Multiple Sclerosis
por: Voigt, Isabel, et al.
Publicado: (2021)

Alterations of the Fecal Microbiota in Chinese Patients With Multiple Sclerosis
por: Ling, Zongxin, et al.
Publicado: (2020)

Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis
por: Yang, Fan, et al.
Publicado: (2021)

Selective Modulation of TNF–TNFRs Signaling: Insights for Multiple Sclerosis Treatment
por: Pegoretti, Valentina, et al.
Publicado: (2018)

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
por: Khoy, Kathy, et al.
Publicado: (2020)

Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
por: Smets, Ide, et al.
Publicado: (2021)

Extracorporeal shockwave therapy combined with alginate dressing for treatment of sacroiliac decubital necrosis in older adults: A case report
por: Duan, Haoyang, et al.
Publicado: (2020)

Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019)

Microglia Diversity in Health and Multiple Sclerosis
por: Zia, Sameera, et al.
Publicado: (2020)

Microglia in Multiple Sclerosis: Friend or Foe?
por: Guerrero, Brooke L., et al.
Publicado: (2020)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Smoking Attributable Risk in Multiple Sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2022)

Multiple sclerosis and obesity: The role of adipokines
por: Correale, Jorge, et al.
Publicado: (2022)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

Targeting Phosphodiesterases—Towards a Tailor-Made Approach in Multiple Sclerosis Treatment
por: Schepers, Melissa, et al.
Publicado: (2019)

Teriflunomide Treatment of Multiple Sclerosis Selectively Modulates CD8 Memory T Cells
por: Tilly, Gaëlle, et al.
Publicado: (2021)

Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
por: Van Wijmeersch, Bart, et al.
Publicado: (2022)

Physical activity and risk of multiple sclerosis: A Mendelian randomization study
por: Li, Chunyu, et al.
Publicado: (2022)

Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review
por: Liu, Pan, et al.
Publicado: (2023)

Rehabilitation challenges in multiple sclerosis
por: Burks, Jack S., et al.
Publicado: (2009)

Mechanisms underlying the beneficial effects of physical exercise on multiple sclerosis: focus on immune cells
por: Zong, Boyi, et al.
Publicado: (2023)

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis
por: Li, Rui, et al.
Publicado: (2016)

Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases
por: Al-Jaderi, Zaidoon, et al.
Publicado: (2016)

Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis
por: Kashani, Nicole, et al.
Publicado: (2021)

Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis
por: Li, Ruoyu, et al.
Publicado: (2022)

Feeding the gut microbiome: impact on multiple sclerosis
por: Bronzini, Matteo, et al.
Publicado: (2023)

Involvement of CD8(+) T Cells in Multiple Sclerosis
por: Salou, Marion, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b7m6boqpf5r2996dpuod5kqio1